Concepedia

Samuel W. Kim

SW

Statistics

Publications

5

Citations

221

H-Index

5

Active since

2016

Affiliations

Barnes-Jewish Hospital(Current)

Washington University in St. Louis

Jewish Hospital

James S. McDonnell Foundation

Nationwide Children's Hospital

Samuel W. Kim is an author at Barnes-Jewish Hospital specializing in cancer vaccines, deoxyribonucleic acid (dna) vaccine, and cancer immunotherapy.

Publications per year

2016–2024

5

Publications

5

Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients

Xiuli Zhang, S. Peter Goedegebuure, Michael Y. Chen et al. · Genome Medicine · 2024 · 74 citations · Full text

, , +17

Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation

Lijin Li, Xiuli Zhang, Xiaoli Wang et al. · Genome Medicine · 2021 · 67 citations · Full text

, , +17

Development of an adenovirus vector vaccine platform for targeting dendritic cells

Piyush Kumar Sharma, Igor P. Dmitriev, Elena A. Kashentseva et al. · Cancer Gene Therapy · 2017 · 36 citations

, , +14

Mammaglobin-A is a target for breast cancer vaccination

Samuel W. Kim, Peter S. Goedegebuure, William E. Gillanders · OncoImmunology · 2016 · 31 citations · Full text

, , +17

Neoantigen DNA vaccines are safe, feasible, and capable of inducing neoantigen-specific immune responses in patients with triple negative breast cancer

Xiuli Zhang, S. Peter Goedegebuure, Nancy B. Myers et al. · medRxiv · 2021 · 13 citations · Full text

, , +17

1–5 of 5